Reply  by Abou-Chebl, Alex et al.
Caron B. Rockman, MD, RVT
New York University Medical Center
New York, NY
doi:10.1016/j.jvs.2005.12.047
Regarding: “Endovascular management of
spontaneous carotid artery dissection”
In the present global enthusiasm for endovascular stenting, a
procedure easy to perform and relatively safe in experienced hands,
we feel there is a serious danger of losing clinical perspective. The
recent article by Edgell et al1 describing the stenting of dissected
carotid arteries warrants especially careful evaluation.
The indications for this procedure in a dissected vessel are far
fromwell defined and relevant to the otherwise benign outcome of
carotid dissection with a spontaneous recurrence rate of only 1% to
2% per year.2 Dissected arteries cannot be equated with atheroscle-
rotic stenosis, because there is a selective vulnerability, probably in
all arteries throughout the body, in these patients due to a genet-
ically determined segmental medial arteriopathy.3
Inserting a stent in these fragile vessels may increase or even
cause further dissection, as occurred in one of the patients in their
case series.1 There is also the potential of the stent, which can be
inserted at an inappropriate time after arterial occlusion, releasing a
pressure head of blood into freshly infarcted tissue (as in case 2),
producing hemorrhagic conversion of an otherwise benign lesion.
This is a time-limiting factor in thrombolytic treatment of ischemic
stroke.
As cautious neurologists, we therefore cannot concur with
Dr Mackey that “. . . aggressive early stenting of traumatic and
spontaneous carotid dissections now warrant careful study.” We
should hasten slowly, primum non nocere.
John W Norris MD
Ranjith K Menon MD
Division of Clinical Neuroscience
St George’s University of London
London, United Kingdom
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I must take issue with the letter from Drs. Norris and Menon.
The report from Drs Edgell, Abou-Chebl and Yadav does not
include cases of uncomplicated carotid dissection and the authors
are not recommending intervention for uncomplicated dissections.
Only 5% of their 135 patients with spontaneous dissection were
treated with stents, and these patients had expanding or symptom-
atic pseudoaneurysms or severe symptomatic flow compromise
because of multi-vessel involvement. What were the treatment
alternatives? The severity of the clinical presentation in these
patients (5 with acute stroke and two with symptomatic expanding
pseudoaneurysms) suggests that watchful waiting was not likely to
be a successful strategy. To quote Shakespeare “. . .diseases des-
perate grown by desperate appliance are relieved, or not at all.”
(Hamlet IV,iii).
Nowhere in their manuscript do Drs Edgell, et al equate
stenting for dissection with stenting for atherosclerotic disease.
They describe in detail their painstaking methods for insuring
cannulation of the true lumen and for avoiding extending the
dissection or entering pseudoaneurysms. Endovascular treatment
of carotid dissections is not a procedure for the carotid stenting
neophyte, and the authors make this very clear.
Drs. Norris and Menon suggest that carotid stenting for
dissection might be accompanied by reperfusion cerebral edema or
hemorrhage, and, in fact, intracranial hemorrhage did occur in one
patient 13 days after the procedure. Intracranial hemorrhage fol-
lowing stroke can occur as a result of anticoagulation as well as
reperfusion, and is most likely to occur in those with very poor
baseline perfusion and significant infarction. The outcome in this
patient may have been even worse without intervention as the
patient was nearly comatose at presentation.
Finally, Drs Norris and Menon feel that we should not move
ahead with a trial to examine the efficacy of more liberal use of
stenting in cases of traumatic and spontaneous carotid dissection.
The principal of “primum non nocere” compels a careful balancing
of risks and benefits prior to any intervention. However, up to 15%
of patients with spontaneous dissection fail medical management,
and many patients with post-traumatic dissection develop strokes
several hours or even days post injury. Many of these are young,
previously healthy individuals for whom a stroke is especially devas-
tating. Why not thoroughly and carefully evaluate every potential
means for preventing such strokes?
William C. Mackey, MD
Division of Vascular Surgery
Tufts New England Medical Center
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We read with interest the comments offered by Drs. Norris
andMenon regarding our article describing stenting for symptom-
atic cervicocranial arterial dissection. We, like Drs. Norris and
Menon, are also “cautious neurologists” and do not undertake
endovascular procedures without just cause. Although spontane-
ous arterial dissections do have a generally benign course, not all
patients recover spontaneously without recurrent or continued
ischemia.1 As we clearly described in the article, the patients we
treated represented approximately 5% of the dissection patients
seen in our institution, and all had either ongoing ischemia or
expanding pseudoaneurysms with increasing mass effect, cranial
neuropathy, or intractable headaches. Three of the patients were in
fact in the midst of a large clinical stroke, which resolved or began
to improve immediately after stenting; the stroke would have likely
been fatal in two of these patients and devastating neurologically in
the other. Much of what we as physicians do on a daily basis in the
practice of medicine relies on skill and art as much as it does on
scientific knowledge. Leaving patients such as ours to complete
large hemispheric strokes because some retrospective, historical
data suggest that most patients have an “otherwise benign out-
come” is careless medicine. Furthermore, most of the natural
history data available in the literature do not include large numbers
of patients such as ours who had multiple simultaneous dissections
and flow-limiting lesions with poor cerebral blood flow. The
medical treatment offered to patients with dissections is in fact
therapy aimed at the prevention of thrombosis and thromboem-
bolism, not therapy aimed at augmenting cerebral blood flow, an
often neglected but important cause of cerebral ischemia. Finally
and most importantly, physicians continue to prescribe antithrom-
botic and anticoagulant therapy to patients with dissections with-
out good efficacy data or safety data for such treatments. There-
fore, it is arguable that there is no proven, effective therapy for
spontaneous arterial dissections, whether medical or endovascular.
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With that said, by publishing our experience we are not
advocating endovascular treatment of all spontaneous dissections.
We clearly wrote that this approach is indicated “when medical
therapy is insufficient or inappropriate.” However, in selected
patients with ongoing symptoms despite medical therapy or those
who present with an acute stroke, endovascular therapy should
be considered. Endovascular therapy carries risk, of course, but
Drs. Norris and Menon overemphasize the importance of a slight
iatrogenic intimal tear, which was the only procedural complica-
tion in our series and which healed spontaneously. In regard to
their statement about the risk of reperfusion/hyperperfusion hem-
orrhage after revascularization, we could not agree more, and to
prevent such an event, it is important to preserve as much viable
brain tissue as possible and to control arterial hypertension. Our
patient who had an intracerebral hemorrhage 13 days after stenting
of both internal carotid artery dissections had presented in a coma
from bilateral, severely flow-limiting, internal carotid artery dissec-
tions. In this patient we believed that the risk of an intracerebral
hemorrhage after stenting was acceptable given the almost certain
mortality from acute bilateral internal carotid artery occlusions,
which is not a “benign lesion,” as Drs. Norris and Menon suggest.
In summary, we agree with the sentiment of the comments
offered by Drs. Norris andMenon, but we believe that each patient
with cerebral ischemia should be evaluated as an individual and
that treatment decisions should be made with the unique needs of
each patient taken into account. Sometimes this can mean an endo-
vascular approach even when medicine is the traditional therapy.
Alex Abou-Chebl, MD
Randall Edgell, MD
Jay Yadav, MD
Cleveland Clinic Foundation
Cleveland, Ohio
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Regarding “Long-term results of carotid stenting are
competitive with surgery”
The article by Bergeron et al1 on the “Long-term results of
carotid stenting are competitive with surgery” concludes that
the results of stenting are competitive with carotid endarterec-
tomy. The study evaluated 221 carotid stents in 193 patients.
After inspection of the data in Table I, the sum of the totals for
Complications of the individual risk factors, lesion factor, and
technical factors plus the total for No complication of the same
individual risk factor, lesion factor, and technical factors are
221 stents. Similarly, in Tables III and IV, the sum of the total
for lesion factors for In-stent restenosis plus the total for Free
from in-stent restenosis is 221 stents; this is also apparent for
the sum of the totals for technical factors. Since the higher than
expected totals are the “global number of patients,” can the
authors define global number ?
Carotid endarterectomy can be achieved with low periopera-
tive complications and is the gold standard for stenting. The 5-,
10-, and 15-year restenosis-free rates and stroke-free rates with the
vein-patch are 91%, 87% and 79%, and 97%, 94% and 93%, respec-
tively.2 The long-term benefit of carotid artery stenting is an
important issue, and an explanation for the increased total number
in the data that was used to obtain their conclusion will help to
weigh the importance of this paper to determine which procedure
would most benefit a patient.
John B. Chang, MD
Theodore A Stein, PhD
Albert Einstein College of Medicine, Bronx, NY
Long Island Vascular Center, Roslyn, NY
REFERENCES
1. Bergeron P, Roux M, Khanoyan P, Douillez V, Bras J, Gay J. Long-term
results of carotid stenting are competitive with surgery. J Vasc Surg
2005;41:213-21.
2. Chang JB, Stein TA. Ten-year outcome after saphenous vein patch
angioplasty in males and females after carotid endarterectomy. Vasc
Endovasc Surg 2002;36:21-7.
doi:10.1016/j.jvs.2005.04.054
Reply
We first intended to publish our experience in endovascular
procedures in carotid arteries, including stenting and balloon
angioplasty in stenoses and aneurysms. After we performed the first
Fisher exact test on this larger cohort, we decided to refine our
results and focus on carotid stenting only for stenotic carotid
diseases. Thus, we withdrew sole balloon angioplasty and carotid
artery aneurysms from the cohort, and the period of the study was
retrospectively extended to September 2003. Unfortunately, the
statistician who performed the initial Fisher’s test died soon after,
and we decided to submit the final manuscript without repeating
the Fisher test on the newly defined cohort that was reported in the
manuscript.
We have subsequently performed a Fisher exact test on the
cohort that we described in our Methods section (ie, without
carotid aneurysms and without sole balloon angioplasty). Of the
seven factors that were found to be independently associated with
neurologic complications after all carotid endovascular interven-
tions, only two have remained statistically significant predictors
with similar P values: preoperative renal insufficiency and age70
years. The use of the femoral access rather than the direct cervical
puncture showed a fivefold increase in the neurologic complica-
tions rate that was not statistically significant. As for predictors of
in-stent restenosis, the Fisher exact test on this cohort did not
demonstrate any predicting factor.
On behalf of all my coworkers and coauthors, I thank Dr
Chang for reviewing our results so cautiously and for pointing out
the dataset shifting between the two cohorts we described in our
Methods and Results sections. Although this error only affected the
results of the Fisher exact test, it has been useful to redo the tests
and confirm that preoperative renal insufficiency and age70 years
are indeed independent predictors of neurologic complications
after carotid stenting. This has also resulted in an erratum pub-
lished in this issue of the Journal of Vascular Surgery.
Patrice Bergeron, MD
Thoracic & Cardiovascular Surgery
St Joseph Hospital
Marseille, France
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